Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

Gilead Sciences26 enrolled

Overview

The objectives of this qualitative study are to elicit concepts about symptoms that are important to patients with primary sclerosing cholangitis (PSC), as well as the key impacts of symptoms on patients' day-to-day functioning.

In Step I, concept elicitation one-on-one interviews (via telephone or in person) will be conducted. The aims of the concept elicitation interviews are to: 1. Identify the most common symptoms, as well as the most important symptoms, for patients with PSC, and 2. Assess whether these symptoms impact day-to-day functioning An instrument will be developed based on the symptoms reported and in Step II of the study, the performance of the instrument will be assessed with further interviews.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Primary Sclerosing Cholangitis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Confirmed diagnosis of PSC based on liver biopsy or diagnostic imaging, with diagnosis made at least three months prior to screening * Patient report of PSC symptoms associated with PSC diagnosis * Able to speak, read, and understand English * Willing and able to provide written informed consent to participate in the research study Exclusion Criteria: * Patients with other causes of liver or biliary disease, including viral hepatitis, alcoholic liver disease, primary biliary cirrhosis, and secondary sclerosing cholangitis * Patient with history of liver cirrhosis * Patients with history of cholangiocarcinoma * Patients who have received a liver transplant * Patients currently enrolled in PSC clinical trials; and * STEP II ONLY: Enrolled in or participated in Step I of this study (concept elicitation)

Locations (5)

University of Colorado Hospital, Denver Health Medical Center

Aurora, Colorado, United States

University of Miami Miller School of Medicine - Schiff Center for Liver Diseases

Miami, Florida, United States

Evidera

Bethesda, Maryland, United States

Duke University Medical Center

Durham, North Carolina, United States

Outcomes

Primary Outcomes

List Primary Sclerosing Cholangitis (PSC) Symptoms for inclusion in patient questionnaire

Interview participants to generate a list of the most common symptoms, as well as the most important symptoms, experienced by patients with PSC, and whether each symptom impacts day-to-day functioning.

Time frame: Up to 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.